ADAM17 and Hepatic steatosis: The TACE/TIMP-3 system has recently emerged as a novel mediator between metabolic stimuli and innate immunity; however, the effects of pharmacologic TACE-inhibition on insulin resistance and hepatic steatosis remain to be established.